v3 Template
T
Theratechnologies Inc.
Biopharmaceuticals
Montreal, Canada
~10 employees
Founded
--
Employees (Est.)
~10
1 leaders known
Total Funding
$193.1M
Funding Rounds
9
Last Funding
2024-12-02
About Theratechnologies Inc.
Theratechnologies is a biopharmaceutical company focused on the development and commercialization of innovative therapies, particularly for people with HIV in the United States.
Products & Services
Trogarzo(r):A prescription product for people with HIV, approved and marketed in the United States.
Specialties
HIV therapies
Innovative therapies development
Commercialization of prescription products
Funding History
Debug: View Raw Funding Data
| # | Type | Amount Fields | Date Fields | Investors |
|---|---|---|---|---|
| 1 |
RT: Debt T: - FT: Debt |
A: 75000000 MR: - FA: up to $75 million FAN: 75000000 |
D: 2024-12-02 FD: 2024-12-02 |
2 investors |
| 2 |
RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement |
A: 25000000 MR: - FA: US$25,000,000 FAN: 25000000 |
D: 2023-10-31 FD: 2023-10-31 |
2 investors |
| 3 |
RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement |
A: 25000000 MR: - FA: US$25 million FAN: 25000000 |
D: 2023-10-26 FD: 2023-10-26 |
2 investors |
| 4 |
RT: Public Offering and Private Placement T: - FT: Public Offering and Private Placement |
A: 12500000 MR: - FA: US$12.5 million FAN: 12500000 |
D: 2023-10-25 FD: 2023-10-25 |
1 investors |
| 5 |
RT: Debt T: - FT: Debt |
A: 600000 MR: - FA: US$600,000 FAN: 600000 |
D: 2023-10-16 FD: 2023-10-16 |
1 investors |
| 6 |
RT: Debt T: - FT: Debt |
A: 15000000 MR: - FA: US$15 million FAN: 15000000 |
D: 2023-07-28 FD: 2023-07-28 |
1 investors |
| 7 |
RT: Term Loan T: - FT: Term Loan |
A: 20000000 MR: - FA: US$20 million FAN: 20000000 |
D: 2023-06-22 FD: 2023-06-22 |
1 investors |
| 8 |
RT: Debt T: - FT: Debt |
A: 20000000 MR: - FA: US$20 million FAN: 20000000 |
D: 2023-02-28 FD: 2023-02-28 |
1 investors |
| 9 |
RT: Stock Purchase T: - FT: Stock Purchase |
A: 13440 MR: - FA: US$13,440 FAN: 13440 |
D: 2022-11-11 FD: 2022-11-11 |
1 investors |
Debt
Latest
2024-12-02
$75.0M
2 investors (Pro only)
Public Offering and Private Placement
2023-10-31
$25.0M
Public Offering and Private Placement
2023-10-26
$25.0M
Growth Metrics
+45%
Employee Growth
YoY
3.2x
Funding Growth
Last Round
12
Markets
Operating
10K+
Customers
Active
Mock Up
Team & Leadership
J
Jocelyn Lafond
Privacy Officer
Recent News
Theratechnologies Inc. Announces New Product Launch
2 days agoCompany unveils innovative solution to transform the industry, expanding market reach and capabilities...
Read more →Leadership Team Expands with Industry Veteran
1 week agoNew executive brings 20+ years of experience to accelerate growth and strategic initiatives...
Read more →Company Recognized as Industry Leader
2 weeks agoReceives prestigious award for innovation and customer satisfaction in competitive market...
Read more →Mock Up
Key Competitors
C1
Competitor Alpha
Series B · $50M raised
C2
Competitor Beta
Series C · $120M raised
C3
Competitor Gamma
Series A · $25M raised
C4
Competitor Delta
Seed · $10M raised
Mock Up
Company Details
- Website
- theratech.com
- Industries
- Biopharmaceuticals
- Company Size
- ~10 employees (est.)
- Locations
-
Montreal, Canada
Montreal
Technology Stack
Discover the backend, frontend, and infrastructure technologies powering this company's products.
Upgrade to Pro